U.S. REITS Stock News

Why Twilio’s latest earnings and KPN partnership are drawing fresh attention Twilio (TWLO) is back on investors’ radar after fourth quarter results came in ahead of guidance, organic revenue growth impressed analysts, and fresh Buy ratings followed, helped by expanding AI focused products and the new RCS partnership with KPN Netherlands. See our latest analysis for Twilio. At a share price of $123.51, Twilio has seen an 8.48% 7 day share price return but a 10.73% decline year to date. The 1...

Aflac stock after recent performance Aflac (AFL) has been relatively steady in recent trading, with a 1-day return of about a 0.8% decline and a flat move over the past week, keeping investors focused on its longer-term record. See our latest analysis for Aflac. At a share price of US$112.43, Aflac’s recent pullback sits against a firmer backdrop, with a 30 day share price return of 1.33% and a 5 year total shareholder return of 151.14%. This suggests sentiment has been supportive over time...

Harry Potter tie-in puts McCormick’s Butterbeer flavors in focus McCormick (MKC) is back in the spotlight after partnering with Warner Bros. Discovery to launch limited edition Harry Potter Butterbeer Finishing Sugar and Butterbeer Flavor across major retailers. The collaboration gives investors a fresh data point on how licensing deals and themed products might influence McCormick’s broad consumer portfolio, which already spans spices, sauces, seasonings, and dessert products worldwide. See...

AbbVie recently reported positive topline Phase 3 results from its AFFIRM trial, showing risankizumab (SKYRIZI) subcutaneous induction led to significantly higher clinical remission and endoscopic response rates than placebo in adults with moderately to severely active Crohn’s disease, with safety consistent with prior data. Because AFFIRM included patients who had already failed multiple advanced therapies, the results highlight SKYRIZI’s potential to address a difficult-to-treat Crohn’s...

The Morning Bull - US Market Morning Update Wednesday, Mar, 4 2026 US stock futures are slightly softer this morning, with E-mini S&P 500 contracts down about 0.2%, as investors juggle stubborn inflation worries and mixed global growth signals. The US 10 year Treasury yield is holding near 4.06%, which indicates borrowing costs remain relatively high and keeps pressure on areas like real estate and smaller, debt heavy companies. At the same time, a large 5.6 million barrel build in US oil...

What Medline’s recent fundamentals mean for investors Medline (MDLN) has drawn fresh attention after investors focused on its latest reported fundamentals, including US$28.4b in revenue, US$1.2b in net income, and single digit annual growth rates across both measures. See our latest analysis for Medline. Despite US$28.4b of revenue and US$1.2b of net income drawing focus to fundamentals, Medline’s recent 1-day share price return of a 3.18% decline and 7-day share price return of an 11.2%...

Onto Innovation Inc. recently reported fourth-quarter 2025 sales of US$266.87 million and full-year 2025 sales of US$1.01 billion, alongside weaker profitability, and issued first-quarter 2026 guidance calling for US$275 million to US$285 million in revenue with a GAAP diluted EPS range of US$0.74 to US$0.84. Despite pressure on net income, the company’s stronger-than-expected international revenue, especially in Japan, Taiwan, and Southeast Asia, has reinforced investor interest in its...

In February 2026, Peoples Group announced a major partnership with Fiserv to power its next-generation Canadian payments infrastructure using Fiserv’s Enterprise Payments Platform and DNA core in the public cloud, supporting instant payments, always-on connectivity, and ISO 20022 data ahead of Payments Canada’s Real-Time Rail rollout. This represents one of Peoples Group’s largest technology investments and highlights how Fiserv’s cloud-based payments stack is increasingly becoming a...

If you are wondering whether Intuitive Surgical's current share price still reflects good value, you are not alone; many investors are asking the same question before making their next move. The stock last closed at US$497.42, with returns of 0.7% over 7 days, a 1.3% decline over 30 days, an 11.5% decline year to date and a 10.9% decline over 1 year, set against gains of 115.6% over 3 years and 112.3% over 5 years. Recent attention on Intuitive Surgical has centred on its position in robotic...

Key recent performance for Semtech (SMTC) With no single headline event in focus, Semtech (SMTC) has still been active on investors’ radar, supported by recent share price moves and the latest reported financial results. The stock shows a 6.4% decline over the past day, while the past month return is about 13% and the past 3 months return is about 23%. Over the past year, the total return is about 150% and the 3 year total return is described as very large. On the fundamentals side, Semtech...

Cavco Industries triggered stock overview Cavco Industries (CVCO) has drawn investor attention after recent share price moves, with the stock up about 15% over the past month while the past 3 months show a modest decline. See our latest analysis for Cavco Industries. While Cavco’s 30 day share price return of 14.5% stands out, year to date share price performance is softer, and the longer term total shareholder returns of 8.5% over 1 year and 154.3% over 5 years show a very different...

Event context and recent share performance Novanta (NOVT) has attracted investor attention after recent share price moves, with the stock closing at US$138.18. The company operates in precision medicine, manufacturing, robotics, automation, and advanced surgery technology. See our latest analysis for Novanta. The recent pullback, with a 1-day share price return of a 1.81% decline to US$138.18, sits against a stronger backdrop, including a 90-day share price return of 20.91% and a 5-year total...

This article examines whether JD.com, at around US$25.64, could be a potential bargain or a value trap by looking closely at what the numbers indicate about the stock. JD.com's share price has recently been under pressure, with declines of 6.8% over 7 days, 10.0% over 30 days, 13.2% year to date, and 35.6%, 40.9% and 68.5% over 1, 3 and 5 years respectively. Recent news flow around JD.com has focused on its position within China's ecommerce sector and on how investor sentiment toward Chinese...

AMETEK (AME) is in focus after reporting Q4 2025 earnings and revenue above forecasts, lifting its 2026 outlook, outlining a $100 million growth investment, and announcing a dividend increase that caught investors’ attention. See our latest analysis for AMETEK. Despite a 2.6% one day share price decline and a flat week, AMETEK’s 5.0% 30 day and 18.1% 90 day share price returns, alongside a 1 year total shareholder return of 29.2%, suggest momentum has recently been building. If this update...

Synopsys stock performance and recent context Synopsys (SNPS) has been under pressure in recent months, with the share price showing a 9% decline over the past month and a similar 9% decline over the past 3 months. Over the past year, Synopsys has recorded a 4.7% negative total return, while revenue of US$8,007.7m and net income of US$1,105.4m sit alongside annual revenue and net income growth figures of 11.9% and 20.3% respectively. See our latest analysis for Synopsys. The recent 7 day...

Core & Main stock: what recent returns say about investor expectations Core & Main (CNM) has drawn fresh attention after a mixed stretch in the share price, with a 1.4% decline over the past day and a 3.5% pullback over the past week. See our latest analysis for Core & Main. Despite the recent pullback, Core & Main’s 90 day share price return of 7.78% and 1 year total shareholder return of 13.64% sit alongside a very large 3 year total shareholder return of about 7x. This suggests that...

GXO Logistics (NYSE:GXO) has entered a new partnership with lingerie retailer Hunkemoller to manage its B2B logistics. The agreement covers operations at a state of the art facility in Almere and is structured as a multi year deal. This is Hunkemoller’s first time outsourcing its B2B logistics operations to an external provider. For you as an investor, this move highlights how GXO Logistics (NYSE:GXO) positions itself as a specialist in complex, tech driven logistics for retailers. The...

If you are wondering whether RLI is offering good value at its recent price, you are not alone. This article will walk through how the current share price stacks up against several valuation checks. RLI shares last closed at US$63.29, with returns of 3.6% over the past week, 8.3% over the past month, 1.3% year to date, a 12.6% decline over the past year, 2.7% over three years, and 37.1% over five years, which gives a mixed picture of recent and longer term performance. Recent headlines...

Agnico Eagle Mines (NYSE:AEM) is back on investors’ radar after a run of strong quarterly earnings beats and rising earnings estimates, which has coincided with solid recent share price gains. See our latest analysis for Agnico Eagle Mines. At a share price of $234.52, Agnico Eagle Mines has seen strong momentum recently, with a 30-day share price return of 23.11% and a year to date share price return of 37.59%. Its 1-year total shareholder return of 147.14% and very large 3-year and 5-year...

NextDecade (NasdaqCM:NEXT) approved positive final investment decisions on Trains 4 and 5 at its Rio Grande LNG Facility. The company executed multiple long term LNG sale and purchase agreements tied to these additional trains. These steps expand NextDecade's planned LNG production capacity and build out its contracted commercial portfolio. NextDecade focuses on developing LNG export capacity at its Rio Grande LNG Facility, positioning itself as a US Gulf Coast supplier to global buyers...

In February and March 2026, Leidos Holdings completed two fixed-rate senior unsecured note offerings totaling about US$1.40 billion and continued rolling out its Terminal Flight Data Manager system, which went live at Reagan National Airport significantly ahead of the typical schedule. The accelerated implementation of this mission-critical airspace modernization program highlights Leidos’ ability to deliver complex government technology projects efficiently while expanding its fixed-income...

Rumors are circulating that Sanofi is considering a significantly higher acquisition bid for Ocular Therapeutix (NasdaqGM:OCUL). The speculation follows recent regulatory developments that may create new or faster FDA approval routes for the company’s ophthalmology programs. Market attention has increased as investors assess what a larger potential offer and altered commercialization timelines could mean for OCUL’s valuation and future role in eye care. Ocular Therapeutix focuses on...

Kyndryl Holdings, Inc. recently reported a past quarter where revenue grew but missed analyst expectations and EPS fell short, even as it expanded AI, cloud, and security offerings, launched a Cyber Defense Operations Center in India, and advanced healthcare AI collaborations in the UK. These developments highlight Kyndryl’s push into integrated AI, cybersecurity, and digital sustainability services, even as weaker earnings raised questions about how quickly that shift can translate into...

In the past week, insurance software provider Guidewire Software announced a multi-year partnership with Sompo Group to roll out its cloud platform globally, received board approval for a share repurchase program, and prepared to report earnings following a quarter that beat revenue expectations but missed billings estimates. Together, the Sompo collaboration, upcoming earnings release, and new buyback authorization highlight how Guidewire is trying to deepen insurer relationships while...